M Pawlikowski

Summary

Affiliation: Medical University
Country: Poland

Publications

  1. pmc Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation
    Hanna Pisarek
    Department of Neuroendocrinology, Medical University, Łódź, Poland
    Thyroid Res 2:1. 2009
  2. ncbi request reprint Chromogranin A in pituitary adenomas: immunohistochemical detection and plasma concentrations
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Medical University, Lodz, Poland
    Folia Histochem Cytobiol 42:245-7. 2004
  3. ncbi request reprint Oncostatic action of melatonin: facts and question marks
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, Sterling str 3, 91 425 Lodz, Poland
    Neuro Endocrinol Lett 23:24-9. 2002
  4. ncbi request reprint Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro
    M Pawlikowski
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University of Lodz, Poland
    J Physiol Pharmacol 58:179-88. 2007
  5. ncbi request reprint Immunohistochemical detection of angiotensin receptors AT1 and AT2 in normal rat pituitary gland, estrogen-induced rat pituitary tumor and human pituitary adenomas
    Marek Pawlikowski
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University, Lodz, Poland
    Folia Histochem Cytobiol 44:173-7. 2006
  6. ncbi request reprint [The incidence of somatostatin receptors in human neoplasms in the light of ex vivo-in vitro studies]
    Marek Pawlikowski
    Institute of Neuroendocrinology, Department of Endocrinology, Medical University, Łódź
    Endokrynol Pol 57:238-43. 2006
  7. ncbi request reprint Immunohistochemical demonstration of nitric oxide synthase (NOS) in the normal rat pituitary gland, estrogen-induced rat pituitary tumor and human pituitary adenomas
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University, Lodz, Poland
    Folia Histochem Cytobiol 41:87-90. 2003
  8. ncbi request reprint Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma
    Marek Pawlikowski
    Department of Neuroendocrinology, Medical University, Lodz, Poland
    Folia Histochem Cytobiol 44:37-41. 2006
  9. ncbi request reprint Somatostatin analogs - from new molecules to new applications
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, Sterling str 3, 91425 Lodz, Poland
    Curr Opin Pharmacol 4:608-13. 2004
  10. ncbi request reprint Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, 91 425 Lodz, Sterling str 3, Poland
    Neuro Endocrinol Lett 23:17-9. 2002

Collaborators

Detail Information

Publications55

  1. pmc Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation
    Hanna Pisarek
    Department of Neuroendocrinology, Medical University, Łódź, Poland
    Thyroid Res 2:1. 2009
    ..8% for SSTR 1, 2A, 3 subtypes, in 22.2% for SSTR 4 and in 100% for SSTR 5. It suggests that somatostatin multiligand analogs or selective SSTR 1 agonists may be used in thyroid tumors treatment...
  2. ncbi request reprint Chromogranin A in pituitary adenomas: immunohistochemical detection and plasma concentrations
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Medical University, Lodz, Poland
    Folia Histochem Cytobiol 42:245-7. 2004
    ..a half of the examined patients, being more frequent in gonadotropinomas and null cell adenomas. It may have some, although limited, diagnostic value in these types of pituitary tumors...
  3. ncbi request reprint Oncostatic action of melatonin: facts and question marks
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, Sterling str 3, 91 425 Lodz, Poland
    Neuro Endocrinol Lett 23:24-9. 2002
    ..However, the recent data from our and other laboratories suggest also the involvement of RZR/ROR receptors (the putative melatonin nuclear receptors) in both melatonin-induced proliferation inhibition and apoptosis...
  4. ncbi request reprint Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro
    M Pawlikowski
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University of Lodz, Poland
    J Physiol Pharmacol 58:179-88. 2007
    ..The data suggest that the inhibition of CgA (and possibly of alpha-SU) release by SST is mediated via subtypes sst2A, sst3 and sst5, whereas sst2B subtype may induce the opposite effect...
  5. ncbi request reprint Immunohistochemical detection of angiotensin receptors AT1 and AT2 in normal rat pituitary gland, estrogen-induced rat pituitary tumor and human pituitary adenomas
    Marek Pawlikowski
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University, Lodz, Poland
    Folia Histochem Cytobiol 44:173-7. 2006
    ..The expression of AT2 receptors, in turn, may be connected with the process of tumoral neo-angiogenesis...
  6. ncbi request reprint [The incidence of somatostatin receptors in human neoplasms in the light of ex vivo-in vitro studies]
    Marek Pawlikowski
    Institute of Neuroendocrinology, Department of Endocrinology, Medical University, Łódź
    Endokrynol Pol 57:238-43. 2006
    ....
  7. ncbi request reprint Immunohistochemical demonstration of nitric oxide synthase (NOS) in the normal rat pituitary gland, estrogen-induced rat pituitary tumor and human pituitary adenomas
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University, Lodz, Poland
    Folia Histochem Cytobiol 41:87-90. 2003
    ..NOS immunoreactivity is also detectable in all but two human pituitary adenomas and seems to negatively correlate with microvascularization...
  8. ncbi request reprint Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma
    Marek Pawlikowski
    Department of Neuroendocrinology, Medical University, Lodz, Poland
    Folia Histochem Cytobiol 44:37-41. 2006
    ..These findings suggest that the proliferative potential of pituitary adenomas is related to the tumor recurrence and hormone expression...
  9. ncbi request reprint Somatostatin analogs - from new molecules to new applications
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, Sterling str 3, 91425 Lodz, Poland
    Curr Opin Pharmacol 4:608-13. 2004
    ..The development of SST analogs coupled to radioisotopes or cytotoxic drugs, which allows the selective destruction of tumor cells overexpressing sst receptors, constitutes another field of progress...
  10. ncbi request reprint Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, 91 425 Lodz, Sterling str 3, Poland
    Neuro Endocrinol Lett 23:17-9. 2002
    ..Therefore, an open pilot study on the effects of melatonin administration on some sleep parameters, routine hematological and biochemical parameters, and concentrations of hormones was performed in elderly women...
  11. ncbi request reprint "Silent"corticotropinoma
    Marek Pawlikowski
    Department of Neuroendocrinology and Clinical Endocrinology, Medical University of Lodz, Sterling, Poland
    Neuro Endocrinol Lett 29:347-50. 2008
    ..The aim of the study was to evaluate the ACTH-immunopositive pituitary adenomas, especially those without manifestation of Cushing's disease..
  12. ncbi request reprint Adrenal cortex -- the next biological clock?
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Chair of Endocrinology, Medical University of Lodz, Lodz, Poland
    Neuro Endocrinol Lett 26:193-5. 2005
    ..This results in the preponderance of apoptosis over proliferation leading to progressive ZR atrophy followed by a decline of secretion of ZR-derived steroid hormones...
  13. ncbi request reprint Somatostatin receptors in GH-secreting pituitary adenomas--their relationship to the response to octreotide
    Marek Pawlikowski
    Department of Neuroendocrinology, Clinical Endocrinology and Neurosurgery and Surgery of Peripheral Nerves, Medical University of Lodz, Poland
    Endokrynol Pol 59:196-9. 2008
    ..Both isoforms of rsst2 mediate the same biological response (inhibition of GH secretion) in GH-secreting and GH/PRL-secreting adenomas...
  14. ncbi request reprint Angiotensins II and IV stimulate the rat adrenocortical cell proliferation acting via different receptors
    M Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, , , Poland
    Endocr Regul 35:139-42. 2001
    ..CONCLUSION: Both Ang II and Ang IV stimulate the adrenocortical cell proliferation in the rat, but they act via different receptors - AT1 in the case of Ang II and non-AT1 (probably AT4) in the case of Ang IV...
  15. ncbi request reprint Antiproliferative effects of melatonin and CGP 52608
    M Karasek
    Laboratory of Electron Microscopy, Chair of Pathomorphology, Medical University of Lodz, Lodz, Poland
    Biol Signals Recept 8:75-8. 1999
    ....
  16. ncbi request reprint Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliferative and pro-apoptotic effects
    A Gruszka
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, Sterling Str. 3, 91-425 Lodz, Poland
    Neuro Endocrinol Lett 22:343-8. 2001
    ..CONCLUSIONS: Summing up, both OCT and BC inhibit PRL secretion and cell proliferation. The anti-tumoral action of BC, and to some extent the action of OCT, is also connected with induction of apoptosis...
  17. ncbi request reprint Correlation between PCNA expression and AgNOR dots in pituitary adenomas
    M Klencki
    Department of Thyroidology, Institute of Endocrinology, , Dr. Sterling St. 3, , Poland
    Endocr Pathol 12:163-9. 2001
    ..The obtained results reveal that the PCNA indexes and estimated parameters of AgNOR dots differ according to tumor aggressiveness...
  18. ncbi request reprint The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro
    A Gruszka
    Chair of Endocrinology, Medical University of Lodz, Poland
    Life Sci 78:689-93. 2006
    ..Further studies are needed to fully evaluate the potential usefulness of these compounds in the pharmacological treatment of "non-functioning" pituitary tumors...
  19. ncbi request reprint Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro
    Hanna Ławnicka
    Department of Immunoendocrinology, Chair of Endocrinology, Medical University of Lodz, Poland
    Neuro Endocrinol Lett 29:113-6. 2008
    ..The aim of the study was to examine the effect of somatostatin (SST) on vascular endothelial growth factor (VEGF) secretion from clinically non-functioning pituitary tumors incubated in vitro...
  20. ncbi request reprint Plurihormonality of pituitary adenomas in light of immunohistochemical studies
    Marek Pawlikowski
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University, Łódź, Poland
    Endokrynol Pol 61:63-6. 2010
    ..However, data on the incidence and the clinical relevance of the pituitary adenoma plurihormonality are still scarce and controversial...
  21. ncbi request reprint Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies
    Hanna Pisarek
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University of Łódź, Poland
    Endokrynol Pol 60:240-51. 2009
    ....
  22. ncbi request reprint Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro
    Anna Gruszka
    Institute of Endocrinology, Medical University of Lodz, Poland
    Neuro Endocrinol Lett 26:51-4. 2005
    ..In the present study we have investigated for the first time the effects of PPAR-gamma receptor ligand rosiglitazone on the rat estrogens-induced, PRL-secreting pituitary tumor cells in vitro...
  23. ncbi request reprint Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro
    Katarzyna Winczyk
    Department of Neuroendocrinology, Medical University of Łódź, Łódź, Poland
    Neuro Endocrinol Lett 30:107-10. 2009
    ..The aim of the present study was to examine the anti-tumour effect of RGZ on human pituitary adenomas in vitro...
  24. ncbi request reprint Immunohistochemical detection of PPARgamma receptors in the human pituitary adenomas: correlation with PCNA
    Katarzyna Winczyk
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University, Lodz, Poland
    Folia Histochem Cytobiol 43:137-41. 2005
    ..The strong expression of PPARgamma in human pituitary adenomas and its possible involvement in control of cell proliferation in these tumors give a good reason for the attempts of their treatment with PPARgamma ligands...
  25. ncbi request reprint Angiotensin peptides regulate angiogenic activity in rat anterior pituitary tumour cell cultures
    Dorota Ptasinska-Wnuk
    Division of Internal Medicine and Cardiology, The M Pirogow Regional Specialist Hospital in Lodz
    Endokrynol Pol 58:478-86. 2007
    ....
  26. ncbi request reprint Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5?
    Hanna Pisarek
    Department of Neuroendocrinology, Medical University, Łódź
    Endokrynol Pol 61:178-81. 2010
    ..In this study we searched for the relationship between the GH inhibitory response to acute octreotide administration and SSTR2A, SSTR2B, and SSTR5 cellular localization...
  27. ncbi request reprint Melatonin inhibits growth of diethylstilbestrol-induced prolactin-secreting pituitary tumor in vitro: possible involvement of nuclear RZR/ROR receptors
    Michal Karasek
    Department of Electron Microscopy, Chair of Pathomorphology, Medical University of Lodz, Lodz, Poland
    J Pineal Res 34:294-6. 2003
    ....
  28. ncbi request reprint Immunohistochemical localization of the somatostatin receptor subtype 2A in the rat adrenal gland
    Hanna Pisarek
    Department of the Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University, Lodz, Poland
    Folia Histochem Cytobiol 40:27-30. 2002
    ....
  29. ncbi request reprint Anti-inflammatory effects of somatostatin analogs on zymosan-induced earlobe inflammation in mice: comparison with dexamethasone and ketoprofen
    I Kurnatowska
    Institute of Endocrinology, , Poland
    Neuroimmunomodulation 9:119-24. 2001
    ..The somatostatin analogs may constitute a new promising group of anti-inflammatory agents...
  30. ncbi request reprint Pregnenolone sulfate modulates angiotensin II-induced inositol 1,4,5-trisphosphate changes in the anterior pituitary of female rat
    A Lachowicz
    Institute of Endocrinology, Department of Experimental Endocrinology and Hormone Research, , Dr. Sterling Street 3, , 91-425, Poland
    Biochem Biophys Res Commun 287:701-4. 2001
    ..There was no difference between the effect of a high and low dose of PREG-S. These results show that PREG-S may modulate AngII action in the anterior pituitary, regardless of the presence of ovary...
  31. ncbi request reprint Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo
    Katarzyna Winczyk
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, Lodz, Poland
    Neuro Endocrinol Lett 23:50-4. 2002
    ....
  32. doi request reprint Immunohistochemical detection of prothymosin alpha in pituitary adenomas--a new marker of tumor recurrence?
    Marek Pawlikowski
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University of Łódź, Łódź, Poland
    Folia Histochem Cytobiol 47:559-62. 2009
    ..However, this conclusion needs to be confirmed in further prospective studies. Moreover, PT alpha may be also useful as an immunohistochemical marker of the intratumoral microvasculature...
  33. ncbi request reprint Serum alpha-subunit elevation after TRH administration: a valuable test in presurgical diagnosis of gonadotropinoma?
    Anna Gruszka
    Dept of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, Poland
    Endokrynol Pol 56:14-8. 2005
    ....
  34. ncbi request reprint Perspectives of new potential therapeutic applications of somatostatin analogs
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, Dr Sterling Str No 3, 91 425 Lodz, Poland
    Neuro Endocrinol Lett 24:21-7. 2003
    ....
  35. ncbi request reprint Somatostatin and its analog enhance the formation of human leukocyte migration inhibiting factor: further evidence for immunomodulatory action of somatostatin
    M Pawlikowski
    Institute of Endocrinology, Medical Academy of Lodz, Poland
    Peptides 8:951-2. 1987
    ..This finding provides additional evidence for the immunomodulatory action of somatostatin...
  36. ncbi request reprint The involvement of angiotensins in the control of prostatic epithelial cell proliferation in the rat
    M Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, , Poland
    Folia Histochem Cytobiol 39:341-3. 2001
    ..These findings suggest the involvement of angiotensins in the control of prostatic growth, acting via the receptors different from the AT1-subtype (presumably via AT4 receptors)...
  37. ncbi request reprint Immunocytochemical prognostic markers in pituitary tumors
    M Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University, , Poland
    Folia Histochem Cytobiol 39:105-6. 2001
    ....
  38. ncbi request reprint Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with pituitary adenomas
    Anna Gruszka
    Dept of Neuroendocrinology, Chair of Endocrinology, Medical University of Lodz, Sterling Str 1 3, 91 425, Lodz, Poland
    Pituitary 8:163-8. 2005
    ..Prospective studies are required to assess the usefulness of circulating endostatin and VEGF as markers of progression or recurrence of pituitary tumors...
  39. ncbi request reprint Immunohistochemical detection of somatostatin receptor subtypes in "clinically nonfunctioning" pituitary adenomas
    Marek Pawlikowski
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, Poland
    Endocr Pathol 14:231-8. 2003
    ..These findings suggest that "non-functioning" pituitary adenomas are potential candidates for therapy with somatostatin analogs targeted mainly to the receptor subtypes 1 and 5...
  40. ncbi request reprint The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma
    Anna Gruszka
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University, Lodz, Poland
    Folia Histochem Cytobiol 42:35-9. 2004
    ....
  41. ncbi request reprint Influence of pineal indoleamines on the mitotic activity of gastric and colonic mucosa epithelial cells in the rat: interaction with omeprazole
    A Lewinski
    Department of Experimental Endocrinology and Hormone Diagnostics, Medical Academy of Lodz, Poland
    J Pineal Res 10:104-8. 1991
    ....
  42. ncbi request reprint Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer
    K Winczyk
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, Poland
    J Pineal Res 31:179-82. 2001
    ....
  43. ncbi request reprint Angiotensins II and IV modulate adrenocortical cell proliferation in ovariectomized rats
    A Siejka
    Department of Clinical Endocrinology, Chair of Endocrinology, Medical University of Lodz, Lodz, Poland
    J Physiol Pharmacol 57:451-61. 2006
    ..These findings suggest that AngII and AngIV modulate adrenocortical cell proliferation in ovariectomized rats...
  44. ncbi request reprint Gastrin and somatostatin levels in patients with gastric cancer
    M Pawlikowski
    Department of Experimental Endocrinology, School of Medicine, Lodz, Poland
    Horm Metab Res 21:89-91. 1989
    ..The impairment of the negative feedback between gastrin and somatostatin secretions in patients with gastric cancer was suggested...
  45. ncbi request reprint Angiotensins II and IV stimulate the activity of tyrosine kinases in estrogen-induced rat pituitary tumors
    Agnieszka Lachowicz Ochedalska
    Department of Experimental Endocrinology and Hormone Diagnostics, Institute of Endocrinology, Medical University of Lodz, Sterling str 3, 91425 Lodz, Poland
    Biochem Biophys Res Commun 297:931-3. 2002
    ..Because the action of both aminopeptidases is necessary to convert AngII into AngIV, this finding suggested that the effect of AngII on TK activity is (at least in part) exerted via AngIV...
  46. doi request reprint SSTR1 and SSTR5 subtypes are the dominant forms of somatostatin receptor in neuroendocrine tumors
    Hanna Pisarek
    Department of Neuroendocrinology, Medical University of Łódź, Poland
    Folia Histochem Cytobiol 48:142-7. 2010
    ..The observed pattern suggests that apart from octreotide and lanreotide, newly synthesized multiligand analogs such as SOM 230, KE 108 or SSTR 1 and SSTR 5 selective analogs could be effective in NETs treatment...
  47. ncbi request reprint Future of melatonin as a therapeutic agent
    Michal Karasek
    Clinic of Endocrinology, Polish Mother s Memorial Hospital Research Institute, Lodz, Poland
    Neuro Endocrinol Lett 23:118-21. 2002
    ..All aspects of the possible therapeutic use of melatonin as well as its safety, dosage, side effects and contraindications are discussed herein based on the round table conference and they are presented in this paper...
  48. ncbi request reprint Growth-inhibitory action of melatonin and thiazolidinedione derivative CGP 52608 on murine 16/C breast cancer cells
    Katarzyna Winczyk
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University of Lodz, Poland
    Neuro Endocrinol Lett 27:351-4. 2006
    ..The aim of present study was to investigate effects of melatonin, the selective ligand for nuclear RZR/ROR receptors - CGP 52608, and methotrexate on growth of murine 16/C breast cancer cells...
  49. ncbi request reprint Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro
    Katarzyna Winczyk
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University of Lodz, Poland
    Neuro Endocrinol Lett 30:657-62. 2009
    ....
  50. doi request reprint Immunohistochemical detection of angiotensin receptors AT1 and AT2 in adrenal tumors
    Marek Pawlikowski
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University of Łódź, Poland pl
    Folia Histochem Cytobiol 46:51-5. 2008
    ..Our data indicates that the expression of AT1 receptors is altered in adrenal cancer and in pheochromocytomas. The expression of AT2 receptors, in turn, may be connected with the process of tumoral neo-angiogenesis...
  51. ncbi request reprint [Hyperprolactinemia: causes, diagnosis, and treatment]
    Michał Karasek
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University, Lodz
    Endokrynol Pol 57:656-62. 2006
    ..Surgery should be performed only in the patients resistant or intolerant to these agents, or in patients who refuse long-term therapy...
  52. doi request reprint Somatostatin receptors in human adrenal gland tumors--immunohistochemical study
    Hanna Pisarek
    Department of Neuroendocrinology, Chair of Endocrinology, Medical University, Łódź, Poland
    Folia Histochem Cytobiol 46:345-51. 2008
    ..Results of the present study demonstrate that somatostatin receptors are expressed in adrenal tumors in a varied manner which is specific in each case. It provides different diagnostic and therapeutic possibilities...
  53. ncbi request reprint [Somatostatin receptors--new diagnostic and therapeutic possibilities]
    Marek Pawlikowski
    Endokrynol Pol 56:4-5. 2005
  54. ncbi request reprint Effect of monthly administration of GHRH (fragment 1-29) with osmotic pump on the rat anterior pituitary
    Ewelina Motylewska
    Department of Immunoendocrinology, Medical University of Łódź, Poland
    Endokrynol Pol 56:927-32. 2005
    ..Summing up, monthly GHRH administration did not induce somatotrope adenomas but it caused serum GH level elevation, what seems to depend partially on the increase of somatotrope number...
  55. ncbi request reprint LAUDATIO: to Professor Marek Pawlikowski, outstanding endocrinologist and great humanist, on his 70th birthday and 50th anniversary of scientific and didactic activity
    Michal Karasek
    Neuro Endocrinol Lett 24:390-1. 2003